FDA Inspection
MSI Express IncMSI Express Inc – FDA Inspection, Jul 3, 2024
Record Details
This FDA Inspection record concerns MSI Express Inc, with an inspection on July 3, 2024, covering drugs.
- Company
- MSI Express Inc
- Inspection Date
- July 3, 2024
- Product Type
- Drugs
- Person
- Meisha R. Sampson (Issuing Officer)
View Company Profile
ID · 98efd5f5-9c91-42a3-a0e6-5695e1acb35a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1242044
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.80(a)Procedures To Be in Writing
Full citation text and observation details available on the Dashboard.
Other FDA inspections of MSI Express Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 17, 2026 | Not classified | Detroit District Office |
Other documents for MSI Express Inc
- FDA Inspection 1285161 - 2026-02-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.